Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Clinics in orthopedic surgery

Volumn 3, Issue 1, 2011, Pages 48-54

  Cho, Yool ^a   Jung, Gu Hee ^b   Chung, So Hak ^b   Kim, Ji Yeon ^b   Choi, Young ^b   Kim, Jae Do ^b  

^a The Armed Forces Capital Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INFANT; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; OSTEOSARCOMA; PRESCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; OSTEOSARCOMA; SURVIVAL RATE; VINCRISTINE; YOUNG ADULT;

MLCS; MLOWN;

EID: 79960999411     PISSN: None     EISSN: 20054408     Source Type: Journal    
DOI: 10.4055/cios.2011.3.1.48     Document Type: Article

References (0)